Subscribe to RSS
DOI: 10.1055/s-0039-1694747
A Clinician's Approach to Peripheral Neuropathy
Publication History
Publication Date:
22 October 2019 (online)
![](https://www.thieme-connect.de/media/sin/201905/lookinside/thumbnails/10-1055-s-0039-1694747_190037-1.jpg)
Abstract
Peripheral neuropathies are a group of disorders that affect the peripheral nervous system, for which hundreds of etiologies have been identified. This article presents a stepwise approach to the evaluation and workup of peripheral neuropathy, which starts with a detailed history of symptoms, family and occupational history, and a neurological as well as general physical exam. Pattern recognition of various neuropathies can help to build a differential diagnosis based on the presentation. Such patterns include acute versus chronic, primary demyelinating versus axonal, hereditary versus acquired, asymmetric versus symmetric, presence of facial palsies, sensory or motor predominant, and presence of prominent autonomic symptoms. Early categorization of the type of neuropathy can help focus the workup for peripheral neuropathy. Nerve conduction studies and electromyography (NCS/EMG) is the primary diagnostic tool in the evaluation of patients with large-fiber polyneuropathy. One of the most important roles of NCS/EMG is to help categorize polyneuropathy as primary axonal versus primary demyelinating. The finding of a primary demyelinating polyneuropathy narrows the differential diagnosis of polyneuropathy dramatically and increases the chances of finding a treatable etiology. Laboratory workup includes serum studies and potentially cerebrospinal fluid, genetic studies, immunological markers, and fat pad biopsy for select patients. Skin biopsy may be used to assess intraepidermal nerve fiber density if small-fiber neuropathy is suspected, and nerve biopsy may be useful in select cases. In recent years, magnetic resonance imaging and neuromuscular ultrasound have also shown promise in the evaluation of peripheral neuropathy. Identification of the etiology of neuropathy is crucial and often time-sensitive, as an increasing number of causes are now reversible or treatable.
-
References
- 1 Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997; 62 (04) 310-318
- 2 Osterberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis--prevalence and clinical characteristics. Eur J Pain 2005; 9 (05) 531-542
- 3 Li Y. Axonal sensorimotor polyneuropathies. Continuum. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1378-1393
- 4 Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981; 10 (03) 222-226
- 5 Lauria G, Hsieh ST, Johansson O. , et al; European Federation of Neurological Societies; Peripheral Nerve Society. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010; 17 (07) 903-912 , e44–e49
- 6 Devata S, Hari P, Markelova N, Li R, Komorowski R, Shidham VB. Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: role of electron microscopy and Congo red stained cell block sections. Cytojournal 2011; 8: 11
- 7 Buchmann SJ, Penzlin AI, Kubasch ML, Illigens BM, Siepmann T. Assessment of sudomotor function. Clin Auton Res 2019; 29 (01) 41-53
- 8 Siao P, Cros DP. Quantitative sensory testing. Phys Med Rehabil Clin N Am 2003; 14 (02) 261-286
- 9 Ishikawa T, Asakura K, Mizutani Y. , et al. MR neurography for the evaluation of CIDP. Muscle Nerve 2017; 55 (04) 483-489
- 10 Mah JK, van Alfen N. Neuromuscular ultrasound: clinical applications and diagnostic values. Can J Neurol Sci 2018; 45 (06) 605-619
- 11 England JD, Gronseth GS, Franklin G. , et al; American Academy of Neurology. Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (02) 177-184
- 12 Malandrini A, Villanova M, Dotti MT, Federico A. Acute inflammatory neuropathy in Charcot-Marie-Tooth disease. Neurology 1999; 52 (04) 859-861
- 13 Marques Jr W, Funayama CAR, Secchin JB. , et al. Coexistence of two chronic neuropathies in a young child: Charcot-Marie-Tooth disease type 1A and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2010; 42 (04) 598-600
- 14 Panosyan FB, Kirk CA, Marking D. , et al. Carpal tunnel syndrome in inherited neuropathies: a retrospective survey. Muscle Nerve 2018; 57 (03) 388-394
- 15 Morgan G, Wilbourn AJ. Cervical radiculopathy and coexisting distal entrapment neuropathies: double-crush syndromes?. Neurology 1998; 50 (01) 78-83
- 16 Rubens O, Logina I, Kravale I, Eglite M, Donaghy M. Peripheral neuropathy in chronic occupational inorganic lead exposure: a clinical and electrophysiological study. J Neurol Neurosurg Psychiatry 2001; 71 (02) 200-204
- 17 Nordentoft T, Andersen EB, Mogensen PH. Initial sensorimotor and delayed autonomic neuropathy in acute thallium poisoning. Neurotoxicology 1998; 19 (03) 421-426
- 18 Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1293-1306
- 19 Yiannikas C, Pollard JD, McLeod JG. Nitrofurantoin neuropathy. Aust N Z J Med 1981; 11 (04) 400-405
- 20 Johnston SR, Burn D, Brooks DJ. Peripheral neuropathy associated with lithium toxicity. J Neurol Neurosurg Psychiatry 1991; 54 (11) 1019-1020
- 21 Shorvon SD, Reynolds EH. Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates. J Neurol Neurosurg Psychiatry 1982; 45 (07) 620-626
- 22 Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med 1998; 338 (22) 1601-1607
- 23 Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 1991; 30 (01) 54-61
- 24 Olney RK. Neuropathies associated with connective tissue disease. Semin Neurol 1998; 18 (01) 63-72
- 25 Logigian EL, Steere AC. Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease. Neurology 1992; 42 (02) 303-311
- 26 Kaku M, Simpson DM. HIV neuropathy. Curr Opin HIV AIDS 2014; 9 (06) 521-526
- 27 Sabin TD, Swift TR. Neurologic complications of leprosy. In: Aminoff MJ, Josephson SA. , eds. Aminoff's Neurology and General Medicine. 5th ed. New York, NY: Elsevier; 2014: 845-856
- 28 Kutlu G, Ertem GT, Coskun O. , et al. Brucella: a cause of peripheral neuropathy. Eur Neurol 2009; 61 (01) 33-38
- 29 Gainsborough N, Hall SM, Hughes RA, Leibowitz S. Sarcoid neuropathy. J Neurol 1991; 238 (03) 177-180
- 30 Bedlack RS, Vu T, Hammans S. , et al. MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2004; 29 (03) 364-368
- 31 Finsterer J. Inherited mitochondrial neuropathies. J Neurol Sci 2011; 304 (1–2): 9-16
- 32 Collins MP, Periquet MI. Non-systemic vasculitic neuropathy. Curr Opin Neurol 2004; 17 (05) 587-598
- 33 Iannella G, Greco A, Granata G. , et al. Granulomatosis with polyangiitis and facial palsy: literature review and insight in the autoimmune pathogenesis. Autoimmun Rev 2016; 15 (07) 621-631
- 34 Pehlivanoglu F, Yasar KK, Sengoz G. Tuberculous meningitis in adults: a review of 160 cases. ScientificWorldJournal 2012; 2012: 169028
- 35 Sathirapanya P, Fujitnirun C, Setthawatcharawanich S. , et al. Peripheral facial paralysis associated with HIV infection: a case series and literature review. Clin Neurol Neurosurg 2018; 172: 124-129
- 36 Gilden DH. Clinical practice. Bell's palsy. N Engl J Med 2004; 351 (13) 1323-1331
- 37 Hadithi M, Stam F, Donker AJ, Dijkmans BA. Sjögren's syndrome: an unusual cause of Bell's palsy. Ann Rheum Dis 2001; 60 (07) 724-725
- 38 Chweya CM, Anzalone CL, Driscoll CLW, Lane JI, Carlson ML. For whom the Bell's toll: recurrent facial nerve paralysis, a retrospective study and systematic review of the literature. Otol Neurotol 2019; 40 (04) 517-528
- 39 Wong K, Sequeira S, Bechtel K. Pediatric bilateral facial paralysis: an unusual presentation of lyme disease. Pediatr Emerg Care 2018 (e-pub ahead of print). Doi: 10.1097/PEC.0000000000001648
- 40 George MK, Pahor AL. Sarcoidosis: a cause for bilateral facial palsy. Ear Nose Throat J 1991; 70 (08) 492-493
- 41 Kumar P, Charaniya R, Bahl A, Ghosh A, Dixit J. Facial diplegia with paresthesia: an uncommon variant of Guillain-Barre syndrome. J Clin Diagn Res 2016; 10 (07) OD01-OD02
- 42 Gaudin RA, Jowett N, Banks CA, Knox CJ, Hadlock TA. Bilateral facial paralysis: a 13-year experience. Plast Reconstr Surg 2016; 138 (04) 879-887
- 43 Wechsler AF, Ho DD. Bilateral Bell's palsy at the time of HIV seroconversion. Neurology 1989; 39 (05) 747-748
- 44 Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 1994; 44 (07) 1198-1202
- 45 Cai Z, Li H, Wang X. , et al. Prognostic factors of Bell's palsy and Ramsay Hunt syndrome. Medicine (Baltimore) 2017; 96 (02) e5898
- 46 Denny MC, Fotino AD. The Heerfordt-Waldenström syndrome as an initial presentation of sarcoidosis. Proc (Bayl Univ Med Cent) 2013; 26 (04) 390-392
- 47 Eviston TJ, Croxson GR, Kennedy PG, Hadlock T, Krishnan AV. Bell's palsy: aetiology, clinical features and multidisciplinary care. J Neurol Neurosurg Psychiatry 2015; 86 (12) 1356-1361
- 48 Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid 1998; 5 (01) 55-66
- 49 Sasaki Md, Leite PG, Leite AG, de Almeida SM. Bilateral peripheral facial palsy secondary to lymphoma in a patient with HIV/AIDS: a case report and literature review. Braz J Infect Dis 2002; 6 (01) 50-54
- 50 Lopate G, Pestronk A, Al-Lozi M. , et al. Peripheral neuropathy in an outpatient cohort of patients with Sjögren's syndrome. Muscle Nerve 2006; 33 (05) 672-676
- 51 Siao P. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 16-1996. A 36-year-old woman with bilateral facial and hand weakness and impaired truncal sensation. N Engl J Med 1996; 334 (21) 1389-1394
- 52 Nagappa M, Taly AB, Mahadevan A. , et al. Tangier's disease: an uncommon cause of facial weakness and non-length dependent demyelinating neuropathy. Ann Indian Acad Neurol 2016; 19 (01) 137-139
- 53 Albers JW, Fink JK. Porphyric neuropathy. Muscle Nerve 2004; 30 (04) 410-422
- 54 Vucic S, Tian D, Chong PST, Cudkowicz ME, Hedley-Whyte ET, Cros D. Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology. Brain 2006; 129 (Pt 12): 3384-3390
- 55 Van Schaik INLJ, Nobile-Orazio E. , et al; Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision. J Peripher Nerv Syst 2010; 15 (04) 295-301
- 56 Delmont E, Benaïm C, Launay M, Sacconi S, Soriani M-H, Desnuelle C. Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition?. J Neurol 2009; 256 (11) 1876-1880
- 57 Larner AJ. A Dictionary of Neurological Signs. 4th ed. Cham: Springer; 2016
- 58 Willison HJ, O'Leary CP, Veitch J. , et al. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 2001; 124 (Pt 10): 1968-1977
- 59 Camdessanché JP, Antoine JC, Honnorat J. , et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 2002; 125 (Pt 1): 166-175
- 60 Rosenfeld CS, Broder LE. Cisplatin-induced autonomic neuropathy. Cancer Treat Rep 1984; 68 (04) 659-660
- 61 Nobile-Orazio E. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. J Peripher Nerv Syst 2014; 19 (01) 2-13
- 62 Albers JW, Robertson Jr WC, Daube JR. Electrodiagnostic findings in acute porphyric neuropathy. Muscle Nerve 1978; 1 (04) 292-296
- 63 Pearn J. Neurology of ciguatera. J Neurol Neurosurg Psychiatry 2001; 70 (01) 4-8
- 64 Auld RB, Bedwell SF. Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide. Can Med Assoc J 1967; 96 (11) 652-654
- 65 Nazir HF, AlFutaisi A, Zacharia M. , et al. Vincristine‐induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement. Pediatr Blood Cancer 2017; 64: e26677
- 66 Dermitzakis EV, Kimiskidis VK, Lazaridis G. , et al. The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer. BMC Neurol 2016; 16 (01) 190
- 67 Manolis AS, Tordjman T, Mack KD, Estes III NA. Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature. Arch Intern Med 1987; 147 (10) 1805-1809
- 68 Hoyle C, Ewing DJ, Parker AC. Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis 1985; 44 (06) 420-424
- 69 Edmonds ME, Jones TC, Saunders WA, Sturrock RD. Autonomic neuropathy in rheumatoid arthritis. BMJ 1979; 2 (6183): 173-175
- 70 Edelman J, Gubbay SS, Zilko PJ. Acute pandysautonomia due to mixed connective tissue disease. Aust N Z J Med 1981; 11 (01) 68-70
- 71 Kim DH, Zeldenrust SR, Low PA, Dyck PJ. Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy. Muscle Nerve 2009; 40 (03) 363-370
- 72 Cable WJ, Kolodny EH, Adams RD. Fabry disease: impaired autonomic function. Neurology 1982; 32 (05) 498-502
- 73 Vallet A-E, Verschueren A, Petiot P. , et al. Neurological features in adult Triple-A (Allgrove) syndrome. J Neurol 2012; 259 (01) 39-46
- 74 Singleton R, Helgerson SD, Snyder RD. , et al. Neuropathy in Navajo children: clinical and epidemiologic features. Neurology 1990; 40 (02) 363-367
- 75 Thomas PK. Autonomic involvement in inherited neuropathies. Clin Auton Res 1992; 2 (01) 51-56
- 76 Fernandez A, Hontebeyrie M, Said G. Autonomic neuropathy and immunological abnormalities in Chagas' disease. Clin Auton Res 1992; 2 (06) 409-412
- 77 Piradov MA, Pirogov VN, Popova LM, Avdunina IA. Diphtheritic polyneuropathy: clinical analysis of severe forms. Arch Neurol 2001; 58 (09) 1438-1442
- 78 Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992; 71 (02) 59-72
- 79 Koike H, Tanaka F, Sobue G. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol 2011; 24 (05) 504-510
- 80 Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjogren syndrome. Neurology 2005; 65 (06) 925-927
- 81 Gwathmey KG. Sensory neuronopathies. Muscle Nerve 2016; 53 (01) 8-19
- 82 Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol 2009; 256 (Suppl. 01) 3-8
- 83 Kuntzer T, Antoine JC, Steck AJ. Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies). Muscle Nerve 2004; 30 (03) 255-268
- 84 Szmulewicz DJ, McLean CA, Rodriguez ML. , et al. Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS. Neurology 2014; 82 (16) 1410-1415
- 85 Duggins AJ, McLeod JG, Pollard JD. , et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 1999; 122 (Pt 7): 1383-1390
- 86 Preston DC, Shapiro BE. Needle electromyography. Fundamentals, normal and abnormal patterns. Neurol Clin 2002; 20 (02) 361-396 , vi
- 87 Vucic S, Cairns KD, Black KR, Chong PST, Cros D. Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clin Neurophysiol 2004; 115 (10) 2329-2335
- 88 Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003; 60 (08) (Suppl. 03) S8-S15
- 89 Van den Bergh PY, Hadden RD, Bouche P. , et al; Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision. J Peripher Nerv Syst 2010; 15 (01) 1-9